Related Experiment Video
Updated: May 2, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Pharmacology of cyclic peptides: vancomycin and oxytocin as paradigms
1Institute of Industrial, Social and Environmental Medicine, Medical Faculty, Goethe-University Frankfurt/ Main, Theodor-Stern Kai 7, 60590 Frankfurt/Main. j.schulze@em.uni-frankfurt.de.
Abstract:
Cyclic oligopeptides have been introduced into pharmacological use for uses as diverse as selective release of the clotting factor VIII (von Willebrandt factor) by vasopressin, immune modulation by cyclosporin and antibacterial activity by vancomycin. Even now, 60 years after the first isolation of vancomycin (3,4) and the sequencing of oxytocin (48) these compounds have not lost their important role in clinical use. With regard to pharmacological properties oxytocin (as the peptide identic to the human sequence) and vancomycin (as a nonribosomal bacterial peptide) epitomize the swath of cyclic peptide properties.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Opioid Analgesics: Morphine and Other Natural Cogeners
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

